NovaBridge Biosciences - Ordinary Shares, par value $0.0001 per share (Including Ordinary Shares Underlying American Depository Shares) (NBP)

CUSIP: 44975P103

Q1 2024 13F Holders as of 31 Mar 2024

Security type / class
Equity / Ordinary Shares, par value $0.0001 per share (Including Ordinary Shares Underlying American Depository Shares)
Total 13F shares
12,194,479
Total 13F value
$22,682,620
Holder snapshot 6 visible 7 signals
Share change
-295,206
Put/Call ratio
29%
SEC-reported price per share
$1.86
Number of holders
38
Value change
-$591,267
Number of buys
15
Open additional details 1 more signal available
Number of sells
20
Security identity Names, identifiers, and filing context for this profile. 1 source field
Shares outstanding
265,214,861

Security key

44975P103

Report period

Q1 2024

Institutions

38

Top holders

10

NBP full security history Ownership snapshot Full 13F holder table Newer quarter: Q2 2024 Previous quarter: Q4 2023 NovaBridge Biosciences SEC filings NovaBridge Biosciences company facts

Broader feeds

Latest 13F filings Latest 13D/G filings Investors directory

Ownership snapshot

Top reported holders of NBP - NovaBridge Biosciences - Ordinary Shares, par value $0.0001 per share (Including Ordinary Shares Underlying American Depository Shares) (13F + 13D/G + 3/4/5)

Grouped by holder across the latest SEC ownership disclosures. Start with comparable ownership when available, then verify the linked 13F, 13D/G, or 3/4/5 evidence.

Comparable stake leader
HHLR ADVISORS, LTD.
Disclosed value leader
HHLR ADVISORS, LTD.
Comparable rows
15/15
Latest evidence
31 Dec 2023
13F Lead comparable stake: 2.6% Showing 1-6 of 15 holder rows.

Quick read

HHLR ADVISORS, LTD. leads the comparable SEC ownership view at 2.6%.

15 of 15 rows have a safely comparable ownership percentage. Use this as a filing-backed starting point, then open the detailed table for source links, reporting role, position value, share count, and filing date.

Open SEC evidence Opens HHLR ADVISORS, LTD.'s linked filing trail.
Comparable ownership Top 5
HHLR ADVISORS, LTD. 2.6%
TWO SIGMA INVESTMENTS, LP 0.22%
Temasek Holdings (Private) Ltd 0.21%
TWO SIGMA ADVISERS, LP 0.21%
GSA CAPITAL PARTNERS LLP 0.2%

Ownership % is shown only when SEC disclosures are safely comparable across share classes.

Detailed SEC evidence table Showing 1-6 of 15 holder rows
Holder Evidence Ownership % Position 12M Net Δ As of
HHLR ADVISORS, LTD.
13F
Company
13F
2.6%
$13,127,518
6,909,220 shares
 — 31 Dec 2023
TWO SIGMA INVESTMENTS, LP
13F
Company
13F
0.22%
$1,092,312
574,901 shares
 — 31 Dec 2023
Temasek Holdings (Private) Ltd
13F
Company
13F
0.21%
$1,076,635
566,650 shares
 — 31 Dec 2023
TWO SIGMA ADVISERS, LP
13F
Company
13F
0.21%
$1,061,530
558,700 shares
 — 31 Dec 2023
GSA CAPITAL PARTNERS LLP
13F
Company
13F
0.2%
$1,022,000
538,119 shares
 — 31 Dec 2023
MORGAN STANLEY
13F
Company
13F
0.19%
$981,722
516,696 shares
 — 31 Dec 2023
How to read this table

Rows are grouped by holder and ranked first by SEC-reported ownership % when it is safely comparable, then by disclosed holdings value. — indicates unavailable or non-comparable values; "mixed-class rows" means the latest filing spans non-comparable classes.

13F holder rows

Institutional holders as of Q1 2024

Investor-level positions for this CUSIP, loaded as an interactive table.

Institutions
38
Shares
12,194,479
Rows available
38
Investor Option Weight % Change % SEC-reported value * Price Shares Share Change Activity Report Period

* SEC-reported price is the security price as of the portfolio date and can indicate the last known price at which the security was still held. The marker flags a reported price that did not pass the local price check.

Compare Q1 2024 vs Q4 2023 Across Filers

Q4 2023 holders
43
Q1 2024 holders
38
Holder diff
-5
Investor Q4 2023 Shares Q1 2024 Shares Share Diff Share Chg % Q4 2023 value Q1 2024 value Value change Value Chg %

Trend: ostatnie 8 kwartałów (+ wybrane okresy porównania).

Quarterly Holders Trend
Quarterly Value Trend
Quarterly Shares Trend
We use cookies and similar technologies to provide certain features, enhance the user experience and, if you allow them, measure engagement and deliver advertising. Analytics and marketing storage stay off until you grant consent. By clicking on "Agree and continue", you declare your consent to the use of the selected optional cookies. Manage preferences to update or revoke optional consent for future visits. For more information, see our Privacy Policy .